Correlation Between Kezar Life and Inozyme Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kezar Life and Inozyme Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kezar Life and Inozyme Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kezar Life Sciences and Inozyme Pharma, you can compare the effects of market volatilities on Kezar Life and Inozyme Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kezar Life with a short position of Inozyme Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kezar Life and Inozyme Pharma.

Diversification Opportunities for Kezar Life and Inozyme Pharma

-0.35
  Correlation Coefficient

Very good diversification

The 3 months correlation between Kezar and Inozyme is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Kezar Life Sciences and Inozyme Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inozyme Pharma and Kezar Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kezar Life Sciences are associated (or correlated) with Inozyme Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inozyme Pharma has no effect on the direction of Kezar Life i.e., Kezar Life and Inozyme Pharma go up and down completely randomly.

Pair Corralation between Kezar Life and Inozyme Pharma

Considering the 90-day investment horizon Kezar Life Sciences is expected to under-perform the Inozyme Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Kezar Life Sciences is 1.03 times less risky than Inozyme Pharma. The stock trades about -0.08 of its potential returns per unit of risk. The Inozyme Pharma is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  145.00  in Inozyme Pharma on August 26, 2024 and sell it today you would earn a total of  136.00  from holding Inozyme Pharma or generate 93.79% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Kezar Life Sciences  vs.  Inozyme Pharma

 Performance 
       Timeline  
Kezar Life Sciences 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Kezar Life Sciences are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Kezar Life reported solid returns over the last few months and may actually be approaching a breakup point.
Inozyme Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Inozyme Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Kezar Life and Inozyme Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kezar Life and Inozyme Pharma

The main advantage of trading using opposite Kezar Life and Inozyme Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kezar Life position performs unexpectedly, Inozyme Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inozyme Pharma will offset losses from the drop in Inozyme Pharma's long position.
The idea behind Kezar Life Sciences and Inozyme Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.